Effect Of Combination Antiretroviral Therapy (CART) On Haematological Variables Among People Living With HIV Infection In Gombe, Gombe State, North East Nigeria

Authors

  • G. Aglavdawa Department of Haematology and Blood Transfusion, Federal Teaching Hospital, Gombe, Gombe State. Author
  • S. A. Ufelle Department of Medical Laboratory Science, University of Nigeria, Enugu Campus, Enugu State. Author
  • S. Yuguda Department of Haematology  and  Blood  Transfusion,  Gombe State University/Federal Teaching Hospital, Gombe, Gombe State. Author
  • A. I. Girei   Department of Haematology  and  Blood  Transfusion,  Gombe State University/Federal Teaching Hospital, Gombe, Gombe State. Author
  • S. Adamu Department of Chemical  Pathology, Gombe State University/ Federal Teaching  Hospital,  Gombe,  Gombe State.  Author
  • Y. Abdulsalam   Department of Haematology and Blood Transfusion, Federal Teaching Hospital, Gombe, Gombe State. Author
  • S. M. Yakubu Department of Haematology and Blood Transfusion, Federal Teaching Hospital, Gombe, Gombe State. Author

Keywords:

haematological variable, combination antiretroviral therapy, HIV

Abstract

Background:  Human immunodeficiency viral infection is known to cause haematological abnormalities and coagulopathies by various mechanisms, especially during its late course. Administration of combination antiretroviral therapy (cART) could positively or negatively affect these haematological parameters. Thus, determination  of  the  effect  of  cART  on haematological variables is required early for initiation and monitoring of the disease.  
 
Aim and Objectives:  The aim of the study was to investigate the effect of cART on haematological variables among people living with HIV infection (PLHIV) in Gombe, Gombe state, Nigeria.   Materials and Methods:  A case control study design was conducted among 180 participants, 120 were PLHIV on cART and 60 treatment naïve controls. Blood samples were collected for CD4+ cell count, viral load and complete blood count (CBC)  after  obtaining  informed  consent; and  a  questionnaire  was  used  to  collect sociodemographic and clinical data.   Results:  People  living  with  HIV  infection  on  cART had significantly higher (p < 0.05) Hb (13.01 ± 1.9 vs. 11.2± 2.9g/dl), MCH (33.7 ± 5.0 vs. 28.7 ± 7.5pg), MCV (94.0 ± 11.1 vs. 81.4 ± 7.5fl), MCHC (35.6 ± 1.9 vs. 33.9 ± 3.6g/dl), and platelets (264.0 ± 106.0 vs. 245.6 ± 108.8 x109/L) than treatment naïve individuals. There was no statistically significant difference in WBC count between the two groups, neither was there a significant difference among the groups based on type of cART regimen.  
 
Conclusion:  This study confirms that, cART has positive impact on some haematological variables; thus, has the ability to reduce viral load and boost immune system of PLHIV. The different cART regimens had similar effects on the changes in the haematological variables 

         Views | Download: 96 / 8

Downloads

Download data is not yet available.

References

Kircholoff F, Silvestri G. Haematopoiesis cause of HIV-associated dysfunction. J clin invest. 2018; 118:1622-1625

Belperio PS, Rhew DC. Prevalence and outcomes of Anaemia in individual with Human immunodeficiency Virus; a systematic review of the literature. Am J med. 2014; 116:27-43

De-santis GC, Brunetta DM, Vilar FG. Haematological abnormality in HIV infected patients. Internl J infect Dis. 2011; 2(15):808-811

Van-Rie A, Westtreich D, Sanne I. Tuberculosis in patients receiving antiretroviral treatment; incidence, risk factors and prevention strategies. J Acquired immune defsynd. 2011; 56:349-355.

Evans RH, Scandden A.C. Haematological aspect of HIV infection. Baillieres best practice Resource, Clin Haematol. 2000; 13:215-230.

Antelman GT, Msamanga D, Spiegelman ET, Urassa R, Narh DJ. Nutritional factors and infectious disease contribute to anaemia among pregnant women with Human immunodeficiency virus in Tanzania. J Nutr. 2000; 130:1950-1957

Enawgaw B, Alem B, Addis Z, Melku M. Haematological changes in HIV infected patients. J med virol. 2014; 7(4):150-154.

Firnhaber C, Smeaton L, Saukila N. Comparison of Anaemia, Thrombocytopenia and neutropenia at the initiation of antiretroviral therapy in Africa, Asia and the America. Intern J infect dis. 2010; 3:1088-1092

Aragaopm, M., Marques A, H. Thrombocytopenia associated with HIV/AIDS patients. Brazilian J Acquired ImmunSynd. 2005; 4:165-188

Bello IM, Gashau F, Kida SH, Ajayi B. Relationship between some haematological abnormalities, degree of immunosuppression and viral load in treatment of naïve HIV infected patients: East med health J. 2012; 19(4):362-368

Bolton- Moore C, Mubiana-Mbewe M, Canfrell RA. Clinical outcome and CD4 cell Response in

children receiving antiretroviral therapy at primary health care facilities in Zambia. J Infect Dis. 2010; 298(16):1888-1899.

Yakubu A, Mohammed HY, Isaac IZ, Aminu A. Some haematological profile of HIV/AIDS patients on Highly Active Antiretroviral Therapy (HAART) in usman Danfodio University Teaching Hospital Sokoto, North Western Nigeria. Am J SciTech.2014; 2(1):27-32

Idowu CO, Oke OT, Afolayan A. Effect of HAART on some haematological variables and CD4 count among HIV clients. Intern J Biol med Res. 2013; 4 (3):3265-3270.

Ogbe PJ, Idoko OA, Ezimah AC, Digban KA, Oguntayo BO. Evaluation of iron status in anaemia of chronic disease among patients with HIV infection. J clin lab med. 2012; 25:7-12

Alem M, Addis Z, Melku M, Enawgaw B. Determination of haematological and immunological parameters among HIV positive patients treatment experienced and treatment naïve at Gondar university hospital, Ethiopia. Comparative cross-sectional study. BMC haematol. 2014; 14(8):8-114

Wesley D, Kufel A, Cory M, Eric F, Cesar E, Christopher D. Nucleoside Reverse Transcriptase DNA inhibition associated macrocytosis. International J virol acq immun synd. 2016; 3(1):18-20.

Kin AH, Jang W, Kin Y, Park YJ, Han K. Mean Corpuscular Volume (MCV) Values reflect therapeutic outcome with Zidovudine among HIV patients. J clin lab infect dis. 2013; 27:373-378.

Akinbami A, Oshinaike O, Adeyemi T. Haematological Abnormalities in treatment naïve HIV patients. Lagos, Nigeria. J Infect Dis 2010; 3:45-49.

Adane A, Desta K, Bezabeh A. HIV associated anaemia before and after initiation of antiretroviral therapy at ART centre of Minilik II Hospital, Adis Ababa, Ethiopia. Ethiopian Med J. 2012; 1:13-21.

Obata K, Mukai K, Tsujimura Y, Ishiwata K, Kawano Y, Minegish Y. Basophils are essential initiators of novel type of chronic allergic inflammation. Journal of blood physiology 2007; 119:913-20

Jiang AP, Jiang JF, Jin YM, Wang J. Human blood circulation basophils among HIV-1 on antiretroviral therapy and meditated viral transinfection of CD4+T cells. Intern J virol. 2015; 89:8050-8062.

Leticia OI, Ugochukwu OE, Ifeanyi A, Andrew A, Ifeoma UE. The correlation values of CD4 count, platelet count, PT, APTT, Fibrinogen and factor VIII concentration among HIV positive on HAART in Owerri. J Dent Med Sci. 2014; 13(9):94-101.

Ifeanyichukwu N, Ibekilo Sylvester OBO, John A, Okeke O. Activated partial thromplastin time, prothrombin, thrombin time and platelets count study in HIV seropositve subjects on HAART at Nnamdi Azikiwe Teaching Hospital, Nnewi. J Transl Biomed. 2016; 4:911-916.

Downloads

Published

2021-01-01

Issue

Section

Articles

How to Cite

Aglavdawa , G., Ufelle , S. A., Yuguda , S., Girei ,A.I., Adamu , S., Abdulsalam ,Y., & Yakubu , S. M. (2021). Effect Of Combination Antiretroviral Therapy (CART) On Haematological Variables Among People Living With HIV Infection In Gombe, Gombe State, North East Nigeria . Nigerian Journal of Haematology, 5(1&amp;2), 14-21. https://njhaem.org.ng/index.php/home/article/view/54

Most read articles by the same author(s)

<< < 1 2 3 4